Call us: 1.877.283.7882 | Monday–Friday: 8:00 AM–4:30 PM ET

Private MD News

Home | News | Female Specific Tests

Drug cuts cases of breast cancer in half

Category: Female Specific Tests

Drug cuts cases of breast cancer in half

A study conducted by a team of researchers at Queen Mary University of London showed that breast cancer development in high-risk women decreased by 53 percent when taking the drug anastrozole. These findings could lead to a new option in cancer prevention for postmenopausal women.

Published in the Lancet, the study gathered nearly 4,000 female participants who were postmenopausal and had high risk of developing breast cancer. Half of the women were given a placebo pill, while the rest were given 1 milligram of anastrozole every day. Lab tests were conducted and reviewed for five years, and the researchers reported that 85 women in the placebo group developed breast cancer, compared to only 40 in the anastrozole group.

"This research is an exciting development in breast cancer prevention. We now know anastrozole should be the drug of choice when it comes to reducing the risk of breast cancer in postmenopausal women with a family history or other risk factors for the disease. This class of drugs is more effective than previous drugs such as tamoxifen and crucially, it has fewer side effects," explained lead researcher Jack Cuzick, Ph.D.

Some side effects from estrogen-depriving drugs include sharp aches and pains, however, they found that the anastrozole group had similar reactions compared to the placebo group. This likely meant that the effects were not drug related and that worries in the past about the possible side effects were overemphasized.

"This landmark study shows that anastrozole could be valuable in helping to prevent breast cancer in women at higher than average risk of disease. We now need accurate tests that will predict which women will most benefit from anastrozole and those who will have the fewest side-effects," affirmed Kate Law, director of clinical research at Cancer Research UK.

The next step for these researchers will be to recommend that anastrozole be added to doctors' lists of drugs for breast cancer prevention.

"By including this drug in their clinical guidelines, more women will benefit from this important advancement in preventive medicine," concluded Cuzick.

Currently, the drug Arimidex is prescribed to patients for breast cancer prevention, as it inhibits estrogen in postmenopausal women. Following the results of this study, the usage of anastrozole as treatment could begin to rise.

Menopause and cancer risk
The risk of developing cancer increases as women age due to the development of menopause. Women who have been through natural menopause and are older are more likely to develop cancer. Additionally, some cancer treatments do result in menopausal symptoms in both men and women.

Symptoms of menopause include hot flashes, night sweats, sleeplessness and mood swings. Individuals who feel they are at risk should look into lab tests online in order to screen themselves for risk factors.

Related Articles from Private MD:

Share on Facebook

Subscribe to Private MD Health News RSS Feed: Subscribe

News Categories:

Advanced Lipid Treatment I   Allergy Testing   Anemia and RBC disorders   Autoimmune Diseases   Bariatric Lab Testing   Blood and Blood Diseases   Breast   Cancer Detection and Tumor Markers   Celiac Disease Testing   Chlamydia   Coagulation and blood clotting disorders   Colon   Diabetes   DNA, Paternity and Genetic testing   Drug Screening   Environmental Toxin Testing   Female Specific Tests   Gastrointestinal Diseases   General Health   General Wellness   Heart Health and Cholesterol   Herpes   HIV   HIV monitoring/Treatment/Testing/Post Diagnos   Hormones and Metabolism   Infectious Diseases   Infertility Testing-Male   Infertitlity Hormone Testing   Kidney Diseases   Leukemia and WBC disorders   Liver   Liver Diseases   Lyme Disease   Male Specific Tests   Menopause/Peri-Menopausal Diagnosis   Musculoskeletal Diseases   Organ Specific Testing   Ovarian   Prostate   Sexually Transmitted Diseases   Thyroid Diseases   Transgender Hormone Testing-female to male   Transgender Hormone Testing-Male to Female   Vitamin D Deficiency-Diagnosis and Treatment   

Visit the Health News Archive: Click Here

Questions about online blood testing or how to order a lab test? Click here to get started or call us toll-free at 1.877.283.7882. Our professionals are ready to assist you.

Back to top